pI: 7.2559 |
Length (AA): 1645 |
MW (Da): 182009 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 67 | 1dcq (A) | 431 | 497 | 12.00 | 0.0000085 | 0.04 | 0.55 | -0.83 |
1 | 179 | 1n11 (A) | 419 | 616 | 15.00 | 0 | 0.4 | 1.05 | -0.05 |
70 | 756 | 3cww (A) | 52 | 695 | 32.00 | 0 | 1 | 0.767129 | -0.21 |
72 | 720 | 4iof (B) | 54 | 657 | 36.00 | 0 | 1 | 0.488829 | 0.89 |
85 | 335 | 5cio (A) | 7 | 258 | 29.00 | 0.0013 | 1 | 0.556084 | -0.45 |
948 | 1170 | 4lhk (A) | 31 | 239 | 19.00 | 0 | 0.06 | 0.200062 | -0.45 |
1031 | 1137 | 5fu5 (A) | 1066 | 1172 | 9.00 | 0 | 0.01 | 0.203546 | -1.37 |
1306 | 1409 | 2uvo (A) | 44 | 136 | 33.00 | 0.18 | 0.29 | 0.250522 | -0.65 |
1433 | 1612 | 3ivl (A) | 273 | 455 | 12.00 | 0 | 0.92 | 0.149922 | -0.04 |
1503 | 1607 | 5k5a (B) | 85 | 216 | 31.00 | 0.84 | 0.29 | 0.26013 | 0.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 Oocyst. | Fritz HM |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Ortholog group members (OG5_126910)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G57470 | insulinase family protein |
Arabidopsis thaliana | AT1G06900 | Insulinase (peptidase family M16) family protein |
Arabidopsis thaliana | AT2G41790 | zinc-metallopeptidase PXM16 |
Brugia malayi | Bm1_26615 | insulin-degrading enzyme |
Candida albicans | CaO19.5561 | likely protease similar to S. cerevisiae STE23 (YLR389C) involved in a-factor maturation |
Candida albicans | CaO19.13007 | likely protease similar to S. cerevisiae STE23 (YLR389C) involved in a-factor maturation |
Caenorhabditis elegans | CELE_C02G6.1 | Protein C02G6.1 |
Caenorhabditis elegans | CELE_C28F5.4 | Protein C28F5.4 |
Caenorhabditis elegans | CELE_Y70C5C.1 | Protein Y70C5C.1 |
Caenorhabditis elegans | CELE_C02G6.2 | Protein C02G6.2 |
Caenorhabditis elegans | CELE_F44E7.4 | Protein F44E7.4, isoform C |
Cryptosporidium hominis | Chro.20103 | involved in a-factor processing; Ste23p |
Cryptosporidium hominis | Chro.20104 | ENSANGP00000016000 |
Cryptosporidium parvum | cgd2_920 | peptidaseinsulinase-like peptidase |
Cryptosporidium parvum | cgd2_930 | peptidaseinsulinase-like peptidase |
Chlamydia trachomatis | CT_806 | insulinase family protease III |
Dictyostelium discoideum | DDB_G0287851 | hypothetical protein |
Drosophila melanogaster | Dmel_CG2025 | CG2025 gene product from transcript CG2025-RA |
Drosophila melanogaster | Dmel_CG10588 | CG10588 gene product from transcript CG10588-RB |
Drosophila melanogaster | Dmel_CG5517 | Insulin degrading metalloproteinase |
Escherichia coli | b2821 | protease III |
Echinococcus granulosus | EgrG_000765600 | insulin degrading enzyme |
Echinococcus granulosus | EgrG_000935900 | nardilysin |
Echinococcus granulosus | EgrG_000921800 | 3'partial|nardilysin |
Echinococcus multilocularis | EmuJ_000765600 | insulin degrading enzyme |
Echinococcus multilocularis | EmuJ_000935900 | nardilysin |
Echinococcus multilocularis | EmuJ_000921800 | nardilysin |
Echinococcus multilocularis | EmuJ_000935700 | nardilysin |
Homo sapiens | ENSG00000078618 | nardilysin (N-arginine dibasic convertase) |
Homo sapiens | ENSG00000119912 | insulin-degrading enzyme |
Leishmania braziliensis | LbrM.31.3520 | phosphoglycan beta 1,3 galactosyltransferase 5 |
Leishmania braziliensis | LbrM.31.3470 | phosphoglycan beta 1,3 galactosyltransferase 5 |
Leishmania donovani | LdBPK_313210.1 | phosphoglycan beta 1,3 galactosyltransferase 5 |
Leishmania infantum | LinJ.31.3210 | phosphoglycan beta 1,3 galactosyltransferase 5 |
Leishmania major | LmjF.31.3090 | phosphoglycan beta 1,3 galactosyltransferase 5 |
Leishmania mexicana | LmxM.30.3090 | peptidase, putative,metallo-peptidase, Clan ME, Family M16 |
Loa Loa (eye worm) | LOAG_08082 | insulin-degrading enzyme |
Mus musculus | ENSMUSG00000056999 | insulin degrading enzyme |
Mus musculus | ENSMUSG00000053510 | nardilysin, N-arginine dibasic convertase, NRD convertase 1 |
Neospora caninum | NCLIV_036700 | M16 family peptidase, putative |
Neospora caninum | NCLIV_019040 | Peptidase M16 domain protein, related |
Oryza sativa | 4343659 | Os07g0570300 |
Oryza sativa | 4332762 | Os03g0336300 |
Oryza sativa | 4326434 | Os01g0779100 |
Oryza sativa | 4326432 | Os01g0778800 |
Oryza sativa | 4343660 | Os07g0570500 |
Saccharomyces cerevisiae | YLR389C | Ste23p |
Schistosoma japonicum | Sjp_0009920 | ko:K01408 insulysin [EC3.4.24.56], putative |
Schistosoma japonicum | Sjp_0208470 | ko:K01411 nardilysin [EC3.4.24.61], putative |
Schistosoma japonicum | Sjp_0009910 | ko:K01408 insulysin [EC3.4.24.56], putative |
Schistosoma mansoni | Smp_061510.2 | nardilysin (M16 family) |
Schistosoma mansoni | Smp_146010 | insulysin unit 3 (M16 family) |
Schistosoma mansoni | Smp_128100 | insulysin (M16 family) |
Schistosoma mansoni | Smp_061510.1 | nardilysin (M16 family) |
Schistosoma mansoni | Smp_011100 | insulysin unit 3 (M16 family) |
Schmidtea mediterranea | mk4.016155.00 | Insulin-degrading enzyme |
Schmidtea mediterranea | mk4.000765.07 | Nardilysin |
Schmidtea mediterranea | mk4.000756.05 | Nardilysin |
Schmidtea mediterranea | mk4.002922.03 | Nardilysin |
Schmidtea mediterranea | mk4.000765.06 | Insulin-degrading enzyme |
Schmidtea mediterranea | mk4.024270.00 | |
Schmidtea mediterranea | mk4.000185.08 | Nardilysin |
Schmidtea mediterranea | mk4.030516.01 | |
Schmidtea mediterranea | mk4.018476.00 | Insulin-degrading enzyme |
Trypanosoma brucei gambiense | Tbg972.8.7240 | peptidase, putative,metallo-peptidase, Clan ME, Family M16, putative |
Trypanosoma brucei | Tb927.8.7020 | peptidase, putative |
Trypanosoma congolense | TcIL3000_8_7090 | peptidase, putative |
Trypanosoma congolense | TcIL3000_8_7000 | peptidase, putative |
Trypanosoma cruzi | TcCLB.507389.70 | peptidase, putative |
Trypanosoma cruzi | TcCLB.509911.90 | peptidase, putative |
Toxoplasma gondii | TGME49_244490 | insulysin, putative |
Toxoplasma gondii | TGME49_257010 | sporozoite developmental protein |
Toxoplasma gondii | TGME49_269885 | rhoptry metalloprotease toxolysin TLN1 |
Toxoplasma gondii | TGME49_244480 | peptidase M16 inactive domain-containing protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.7020 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.7020 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.7020 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.7020 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2821 | Escherichia coli | non-essential | goodall |
TGME49_244480 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_269885 this record | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_244490 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_257010 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_244480 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_269885 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_244490 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_257010 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | insulin-degrading enzyme | Compounds | References |
Mus musculus | insulin degrading enzyme | Compounds | References |